Emergent BioSolutions (EBS) Profit After Tax (2011 - 2026)
Emergent BioSolutions (EBS) posted Profit After Tax of -$180.2 million for Q2 2026, compared with -$12 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) Profit After Tax (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Profit After Tax at Emergent BioSolutions was -$176.8 million; for FY2025, it came in at $52.6 million.
- Annual Profit After Tax shows a five-year compound annual growth rate of -29.7% (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Profit After Tax was -$190.6 million in FY2024, -$760.5 million in FY2023, -$211.6 million in FY2022 and $219.5 million in FY2021 (-28.2%).
- The Q2 2026 figure stands as the lowest quarterly Profit After Tax since Q2 2024.
- According to Business Quant data, Profit After Tax for the three prior quarters was $6.8 million (Q1 2026), -$54.6 million (Q4 2025) and $51.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Emergent BioSolutions | 319.92 Mn | -430.98 Mn | 137.20 Mn | -180.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -180.20 Mn |
| Mar 31, 2026 | 6.80 Mn |
| Dec 31, 2025 | -54.60 Mn |
| Sep 30, 2025 | 51.20 Mn |
| Jun 30, 2025 | -12.00 Mn |
| Mar 31, 2025 | 68.00 Mn |
| Dec 31, 2024 | -31.30 Mn |
| Sep 30, 2024 | 114.80 Mn |
| Jun 30, 2024 | -283.10 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | -49.50 Mn |
| Sep 30, 2023 | -263.40 Mn |
| Jun 30, 2023 | -261.40 Mn |
| Mar 31, 2023 | -186.20 Mn |
| Dec 31, 2022 | -67.00 Mn |
| Sep 30, 2022 | -87.10 Mn |
| Jun 30, 2022 | -56.40 Mn |
| Mar 31, 2022 | -3.70 Mn |
| Dec 31, 2021 | 177.90 Mn |
| Sep 30, 2021 | -32.70 Mn |
API Access
Emergent BioSolutions Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();